Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Structural basis of cyclin-dependent kinase activation by phosphorylation.

Russo AA, Jeffrey PD, Pavletich NP.

Nat Struct Biol. 1996 Aug;3(8):696-700.

PMID:
8756328
2.

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massagué J, Pavletich NP.

Nature. 1995 Jul 27;376(6538):313-20.

PMID:
7630397
3.

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.

Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA.

J Biol Chem. 1999 Mar 26;274(13):8746-56.

4.

Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.

Morris MC, Gondeau C, Tainer JA, Divita G.

J Biol Chem. 2002 Jun 28;277(26):23847-53. Epub 2002 Apr 16.

5.

Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate.

Davies TG, Tunnah P, Meijer L, Marko D, Eisenbrand G, Endicott JA, Noble ME.

Structure. 2001 May 9;9(5):389-97.

6.

Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

Garrett S, Barton WA, Knights R, Jin P, Morgan DO, Fisher RP.

Mol Cell Biol. 2001 Jan;21(1):88-99.

7.

The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.

Kaldis P, Cheng A, Solomon MJ.

J Biol Chem. 2000 Oct 20;275(42):32578-84.

8.

Crystal structure of cyclin-dependent kinase 2.

De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH.

Nature. 1993 Jun 17;363(6430):595-602.

PMID:
8510751
9.

Structural basis for CDK6 activation by a virus-encoded cyclin.

Schulze-Gahmen U, Kim SH.

Nat Struct Biol. 2002 Mar;9(3):177-81.

PMID:
11828325
10.

Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.

Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, Barford D.

Mol Cell. 2001 Mar;7(3):615-26.

11.

The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Brown NR, Noble ME, Endicott JA, Johnson LN.

Nat Cell Biol. 1999 Nov;1(7):438-43.

PMID:
10559988
12.

The complete pathway for catalytic activation of the mitogen-activated protein kinase, ERK2.

Prowse CN, Deal MS, Lew J.

J Biol Chem. 2001 Nov 2;276(44):40817-23. Epub 2001 Aug 27.

13.
14.

Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.

Hashimoto Y, Kohri K, Kaneko Y, Morisaki H, Kato T, Ikeda K, Nakanishi M.

J Biol Chem. 1998 Jun 26;273(26):16544-50.

15.

Picture story. Cyclin switch.

Riddihough G.

Nat Struct Biol. 1995 Aug;2(8):636. No abstract available.

PMID:
7552724
16.

Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Schulman BA, Lindstrom DL, Harlow E.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8.

17.

Kinetic basis for activation of CDK2/cyclin A by phosphorylation.

Hagopian JC, Kirtley MP, Stevenson LM, Gergis RM, Russo AA, Pavletich NP, Parsons SM, Lew J.

J Biol Chem. 2001 Jan 5;276(1):275-80.

18.

Structure of GSK3beta reveals a primed phosphorylation mechanism.

ter Haar E, Coll JT, Austen DA, Hsiao HM, Swenson L, Jain J.

Nat Struct Biol. 2001 Jul;8(7):593-6.

PMID:
11427888
19.

Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1.

Bourne Y, Watson MH, Hickey MJ, Holmes W, Rocque W, Reed SI, Tainer JA.

Cell. 1996 Mar 22;84(6):863-74.

20.

The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.

Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD.

Structure. 2001 Dec;9(12):1143-52.

Supplemental Content

Support Center